Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2017 2
2018 1
2019 2
2020 3
2021 3
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Pulmonary sclerosing pneumocytoma and mortality risk.
Kim SJ, Kang HR, Lee CG, Choi SH, Kim YW, Lee HW, Lee CH. Kim SJ, et al. BMC Pulm Med. 2022 Nov 7;22(1):404. doi: 10.1186/s12890-022-02199-1. BMC Pulm Med. 2022. PMID: 36344955 Free PMC article. Review.
BACKGROUND: Surgical resection is usually recommended for the treatment of pulmonary sclerosing pneumocytoma (PSP). However, no comparative study has demonstrated that surgical resection leads to improved outcomes. ...There were no cases of lymph node or distant met …
BACKGROUND: Surgical resection is usually recommended for the treatment of pulmonary sclerosing pneumocytoma (PSP). However, n …
Comprehensive Genomic and Transcriptomic Analysis of Sclerosing Pneumocytoma.
Yeh YC, Chu PY, Lin SY, Wang SY, Ho HL, Wang YC. Yeh YC, et al. Mod Pathol. 2024 Jan;37(1):100354. doi: 10.1016/j.modpat.2023.100354. Epub 2023 Oct 14. Mod Pathol. 2024. PMID: 37844870
Sclerosing pneumocytoma is a rare and distinct lung neoplasm whose histogenesis and molecular alterations are the subject of ongoing research. ...To the best of our knowledge, this is the first comprehensive investigation of the genomic and transcriptomic characteri …
Sclerosing pneumocytoma is a rare and distinct lung neoplasm whose histogenesis and molecular alterations are the subject of o …
Sclerosing pneumocytoma with carcinoid tumorlets and neuroendocrine cell hyperplasia.
Toro Soto PA, Rivero de Jesús É, Arenas Jiménez J, Aranda López FI. Toro Soto PA, et al. Rev Esp Patol. 2022 Sep;55 Suppl 1:S44-S48. doi: 10.1016/j.patol.2020.02.009. Epub 2020 May 6. Rev Esp Patol. 2022. PMID: 36075662
Sclerosing pneumocytoma is an uncommon pulmonary tumor which generally behaves benignly and occurs predominately in women. ...Taking into account the pluripotentiality of the round cells present in the sclerosing pneumocytoma, with positive staining fo …
Sclerosing pneumocytoma is an uncommon pulmonary tumor which generally behaves benignly and occurs predominately in women. ... …
AKT1 internal tandem duplications and point mutations are the genetic hallmarks of sclerosing pneumocytoma.
Yeh YC, Ho HL, Wu YC, Pan CC, Wang YC, Chou TY. Yeh YC, et al. Mod Pathol. 2020 Mar;33(3):391-403. doi: 10.1038/s41379-019-0357-y. Epub 2019 Sep 16. Mod Pathol. 2020. PMID: 31527710 Free article.
Sclerosing pneumocytoma is a unique benign neoplasm of the lungs. The molecular alterations in sclerosing pneumocytoma are not well understood. ...Our results suggest that AKT1 mutation is the genetic hallmark of sclerosing pneumocytoma. …
Sclerosing pneumocytoma is a unique benign neoplasm of the lungs. The molecular alterations in sclerosing pneumocyto …
Pulmonary sclerosing pneumocytoma - approaching a solitary pulmonary nodule and the limitations of risk prediction models.
Saripalli KR, Wang MQW, Chow CY, Chew SY. Saripalli KR, et al. BMJ Case Rep. 2023 Nov 17;16(11):e257208. doi: 10.1136/bcr-2023-257208. BMJ Case Rep. 2023. PMID: 37977835
The clinical pretest probability of malignancy assessed by risk prediction models such as Brock (19.1%), Mayo Clinic (56.2%) and Herder (51.4%) was discordant. She underwent a percutaneous CT-guided needle biopsy, establishing a diagnosis of pulmonary sclerosing …
The clinical pretest probability of malignancy assessed by risk prediction models such as Brock (19.1%), Mayo Clinic (56.2%) and Herd …
Sclerosing pneumocytoma with metastasis to the mediastinal and regional lymph nodes.
Wang X, Zhang L, Wang Y, Jia X, Wang J, Zhang H. Wang X, et al. Indian J Pathol Microbiol. 2018 Jul-Sep;61(3):407-409. doi: 10.4103/IJPM.IJPM_98_17. Indian J Pathol Microbiol. 2018. PMID: 30004067
Sclerosing pneumocytoma (SP) is an uncommon benign tumor, and metastasis of SP has been rarely reported. ...The tumor diameter was 40 mm, and metastasis to mediastinal and regional lymph nodes was observed. Immunohistochemically, both surface and round cells …
Sclerosing pneumocytoma (SP) is an uncommon benign tumor, and metastasis of SP has been rarely reported. ...The tumor diameter …
Differentiation of pulmonary sclerosing pneumocytoma from solid malignant pulmonary nodules by radiomic analysis on multiphasic CT.
Ni XQ, Yin HK, Fan GH, Shi D, Xu L, Jin D. Ni XQ, et al. J Appl Clin Med Phys. 2021 Feb;22(2):158-164. doi: 10.1002/acm2.13154. Epub 2020 Dec 28. J Appl Clin Med Phys. 2021. PMID: 33369106 Free PMC article.
PURPOSE: To investigate the diagnostic value and feasibility of radiomics-based texture analysis in differentiating pulmonary sclerosing pneumocytoma (PSP) from solid malignant pulmonary nodules (SMPN) on single- and three-phase computed tomography (CT) images. ...M …
PURPOSE: To investigate the diagnostic value and feasibility of radiomics-based texture analysis in differentiating pulmonary sclerosing …
Analysis of the F-18 FDG PET/CT features of pulmonary sclerosing pneumocytoma.
Liu H, Dang H, Wang R, Yao S, Wu Y, Xu B. Liu H, et al. Nucl Med Commun. 2021 Jun 1;42(6):665-671. doi: 10.1097/MNM.0000000000001374. Nucl Med Commun. 2021. PMID: 33660695
PURPOSE: This retrospective study aimed to analyzed the F-18 fluorodeoxyglucose PET/computed tomography (F-18 FDG PET/CT) features of pulmonary sclerosing pneumocytoma (PSP) to improve the understanding and preoperative diagnostic efficacy of this rare disorder. ... …
PURPOSE: This retrospective study aimed to analyzed the F-18 fluorodeoxyglucose PET/computed tomography (F-18 FDG PET/CT) features of pulmon …
Case of sclerosing pneumocytoma combined with a typical carcinoid and pulmonary adenocarcinoma in different lobes.
Cho HJ, Lee JH, Lee GK, Hong EK, Kim HY. Cho HJ, et al. Thorac Cancer. 2017 Jul;8(4):372-375. doi: 10.1111/1759-7714.12449. Epub 2017 May 5. Thorac Cancer. 2017. PMID: 28474862 Free PMC article.
We report the first case of a 62-year-old man with a sclerosing pneumocytoma (SP) combined with a typical carcinoid (TC) and pulmonary adenocarcinoma in different lung lobes. ...The radiological diagnosis was primary lung cancer and a metastatic nodule; however, no …
We report the first case of a 62-year-old man with a sclerosing pneumocytoma (SP) combined with a typical carcinoid (TC) and p …
Concomitance of pulmonary spindle cell carcinoma and sclerosing pneumocytoma in a woman: A case report.
LuLu X, Jian S. LuLu X, et al. Medicine (Baltimore). 2019 Dec;98(51):e18416. doi: 10.1097/MD.0000000000018416. Medicine (Baltimore). 2019. PMID: 31861007 Free PMC article.
RATIONALE: Pulmonary spindle cell carcinoma (PSCC) is a rare subset of pulmonary sarcomatoid carcinoma. PSCC is aggressive and has a poor prognosis. Pulmonary sclerosing pneumocytoma (PSP) is an asymptomatic slow-growing benign tumor, which usually occurs in middle- …
RATIONALE: Pulmonary spindle cell carcinoma (PSCC) is a rare subset of pulmonary sarcomatoid carcinoma. PSCC is aggressive and has a poor pr …
13 results